Siteless Virtual Study for Validation of Adverse Events Monitoring Application in Oncology

Siteless Virtual Study for Validation of Adverse Events Monitoring Application in Oncology - ONCOLO Virtual Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038333

Enrollment

100

Registered

2019-10-18

Start date

2019-10-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. The subject is signing informed consent. 2. The subject can prove that they have had cancer. 3. The subject can understand Japanese.

Exclusion criteria

Exclusion criteria: The subject suspected of cognitive decline or psychiatric disorder that may be difficult to meet the requirements of this study

Design outcomes

Primary

Measure	Time frame
1. System error rate (Week0 to Week4) 2. Input rate (Week0 to Week4) 3. QOL change rate (Week0 to Week4) 4. The date collected by wearable device (Week0 to Week4)	—

Countries

Japan

Contacts

Public ContactYuki Nakayama

3H Clinical Trial Inc. LIFTA for Oncology

info_oncolo@3h-ct.co.jp03-5985-0053

Outcome results